UiPath Inc. (PATH)
Market Cap | n/a |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
Shares Out | n/a |
EPS (ttm) | n/a |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 18,516,957 |
Open | 10.89 |
Previous Close | 10.63 |
Day's Range | 10.46 - 10.97 |
52-Week Range | 9.38 - 21.17 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About PATH
There is no company description available. [Read more]
Financial Performance
In 2024, UiPath's revenue was $1.43 billion, an increase of 9.30% compared to the previous year's $1.31 billion. Losses were -$73.69 million, -18.01% less than in 2023.
Financial StatementsNews

UiPath: Ignore The Bearish Noise And Buy This AI Gem
Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong customer retention. PATH leads the growing RPA market, with robust demand and a co...

UiPath Announces AI Partnership with Google Cloud to Transform Medical Processes
NEW YORK & LAS VEGAS--(BUSINESS WIRE)--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.

UiPath: This Market Carnage Is A Perfect Time To Buy This Stock Cheaply
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic automatio...

UiPath Launches Test Cloud to Bring AI Agents to Software Testing
NEW YORK--(BUSINESS WIRE)--UiPath announced UiPath Test Cloud, a new approach to software testing that uses AI to amplify tester productivity across the testing lifecycle.

The Drop In UiPath Stock Unlocks Long-Term Potential
UiPath's ARR is set to hit $1.816B in FY26 (+9% YoY), driven by 98% gross and 110% net retention. Cloud ARR surged past $975M (+50% YoY) as enterprise adoption of AI-driven automation accelerates. Pro...

Coronis Health Enhances Healthcare Delivery Systems through UiPath Platform
SYKESVILLE, Md.--(BUSINESS WIRE)--Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, is pleased to announce that it has leveraged the UiPath Platform™...

UiPath Offers Complimentary Trial of Automation Cloud Public Sector to Assist U.S. Government Agencies' Efficiency Initiatives
NEW YORK--(BUSINESS WIRE)--UiPath announced an Automation Cloud Public Sector free trial to help government agencies address operational challenges & productivity improvements.

UiPath Buys Peak to Bolster Agentic Automation Platform
Enterprise automation and artificial intelligence (AI) software company UiPath has acquired AI platform Peak. “With the acquisition of Peak, we are accelerating our mission to strengthen our vertical ...

UiPath Hit By Slowing ARR Growth, Deal Timing Woes: Analyst Remains Optimistic For AI, Cloud Spark
UiPath Inc PATH stock price declined Thursday after the company reported a fourth-quarter revenue miss.

UiPath Stock Down: Faces Caution Despite Margin Gains, Analyst Doubtful About Company's AI Transition Capability
UiPath, Inc. PATH shares are trading lower on Thursday.

UiPath is looking for a path to growth in agentic AI with its Peak.ai acquisition
A rush of agentic AI solutions is hitting the enterprise market, and now one of the bigger players in automation has scooped up a startup in the space in hopes of taking a bigger piece of that busines...

UiPath Stock Dives. Musk's DOGE Cuts May Be Starting to Hurt Software Companies.
UiPath tumbled after it cited uncertainty over U.S. government spending. as a reason for a disappointing revenue outlook.

UiPath Inc. (PATH) Q4 2025 Earnings Call Transcript
UiPath Inc. (NYSE:PATH) Q4 2025 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Allise Furlani - VP of IR Daniel Dines - Founder and CEO Ashim Gupta - COO and CFO Conference C...

This agentic AI play's stock is falling after it called out ‘increasing global macroeconomic uncertainty'
Shares of UiPath fell sharply after hours on Wednesday after the business-automation software platform forecast sales for the year ahead that came in below Wall Street's expectations.

UiPath Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced financial results for its fourth quarter and full year fiscal 2025 ended ...

UiPath Acquires Peak to Launch Vertically Specialized Agents within its Agentic Automation Platform
NEW YORK--(BUSINESS WIRE)--UiPath announced the acquisition of Peak to launch vertically specialized agents within its agentic automation platform.

UiPath: A Strategic Buy For Growth-Oriented Investors Amid Market Turbulence
UiPath has addressed execution issues from early FY 2025, leading to improved contract execution and new sales compensation plans, driving customer and revenue growth. Organizational restructuring and...

UiPath Stock Is A Buy On The Technical Weakness
The technicals are determined to be highly bearish as signals of weakness are abundant currently. Q3 earnings were mixed and guidance for Q4 was overall weak. However, recent upward EPS revisions show...

UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform
NEW YORK--(BUSINESS WIRE)--UiPath announced a new consulting agreement with a major EMR platform to accelerate professional services programs for customers in 16 new regions.

UiPath: AI Potential Vs. Margin Reality (Rating Downgrade)
UiPath is evolving beyond robotic process automation into an AI-driven model, expanding its market and potentially unlocking margin expansion by automating complex processes. Both UiPath and Palantir ...

UiPath Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results Conference Call
NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced it will report financial results for its fourth quarter and full year fis...

UiPath to Showcase How Agentic Automation is Transforming the Healthcare Industry at ViVE 2025 Conference
NEW YORK--(BUSINESS WIRE)--UiPath announced it is exhibiting at the ViVE 2025 conference at booth #738 to showcase how agentic automation is empowering healthcare organizations.

3 Key Reasons UiPath Is Our Favorite 'Second Layer' AI Play
UiPath's share price has plummeted since IPO, but we see it as a key AI winner for 2025 and beyond. PATH's RPA 'ai agents' automate more business processes than ever, making it indispensable despite C...

UiPath: The Value Keeps Getting Better As This Company Builds AI Agents
UiPath is an excellent and rare value play in the AI space, having fallen ~40% over the past year and trading under

UiPath Report Reveals Agentic AI is Driving Investment to Tackle More Complex Business Workflows
NEW YORK--(BUSINESS WIRE)--UiPath released a new report that reveals 90% of IT executives have business processes that would be improved by agentic AI.